Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hutchison China Meditech

16.39
+0.41002.57%
Post-market: 16.390.00000.00%16:10 EDT
Volume:17.27K
Turnover:281.79K
Market Cap:2.86B
PE:6.19
High:16.40
Open:16.14
Low:16.13
Close:15.98
52wk High:21.50
52wk Low:11.51
Shares:174.43M
Float Shares:104.00M
Volume Ratio:0.21
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.65
EPS(LYR):0.2205
ROE:46.90%
ROA:-0.81%
PB:2.33
PE(LYR):74.32

Loading ...

Lexicon Pharmaceuticals Convenes Roundtable to Address Public Policy Gaps for People with Chronic Pain

GlobeNewswire
·
Yesterday

Dayforce Expands Collaboration with Microsoft to Transform HCM Workflows With AI

GlobeNewswire
·
Yesterday

Telenor Taps Infosys For HR Makeover On Oracle Cloud

Benzinga_recent_news
·
Oct 03

Tenaya Therapeutics to Participate in Upcoming October Investor Conferences

GlobeNewswire
·
Oct 03

HUTCHMED (00013) to Present Clinical Data at 2025 European Society for Medical Oncology (ESMO) Annual Conference

Stock News
·
Oct 02

Paylocity Named Official HCM Partner of the New York Islanders and Official Partner of UBS Arena

GlobeNewswire
·
Oct 01

Humanforce Appoints Aaron Thorne as Chief Sales Officer to Drive Growth Across Frontline Workforces Globally

prnewswire
·
Sep 30

Cytokinetics’ Aficamten Shows Superior Efficacy in Phase 3 MAPLE-HCM Trial, Boosting Stock Outlook

TIPRANKS
·
Sep 29

Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025

GlobeNewswire
·
Sep 29

Mastek Revolutionizes Harmony Australasia’s HR with Oracle HCM Cloud

TIPRANKS
·
Sep 29

Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program

GlobeNewswire
·
Sep 24

Morgan Stanley downgrades HUTCHMED (China) (HCM) to a Sell

TIPRANKS
·
Sep 22

Hutchmed downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Sep 22

HCM III Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 22, 2025

GlobeNewswire
·
Sep 20

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 19

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
Sep 19

Press Release: Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025

Dow Jones
·
Sep 18

Workday AI Push Signals Durable Growth And Sharper Margins Ahead

Benzinga_recent_news
·
Sep 17

Pilavapadin Provides Meaningful Pain Reduction in Adults with Diabetic Peripheral Neuropathic Pain (DPNP) in Data Presented at the European Association for the Study of Diabetes (EASD) and NEUROdiab Annual Meetings

GlobeNewswire
·
Sep 17

Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes

GlobeNewswire
·
Sep 17